1 doctor weighed in:

Is neo 102 drug effective for colon cancer mets. ? Is it different to chemotherpay ?

1 doctor weighed in
Dr. Eric Chevlen
Internal Medicine - Oncology

In brief: Investigational

NEO 102 is a monoclonal antibody, not what is usually meant by the word chemotherapy.
It is the subject of ongoing clinical trials. Therefore it is not yet known whether the drug is useful, harmful, or indifferent. In the U.S. it would only be available for subjects in a clinical trial. I suspect, but am not certain, that that is true in the U.K. Too.

In brief: Investigational

NEO 102 is a monoclonal antibody, not what is usually meant by the word chemotherapy.
It is the subject of ongoing clinical trials. Therefore it is not yet known whether the drug is useful, harmful, or indifferent. In the U.S. it would only be available for subjects in a clinical trial. I suspect, but am not certain, that that is true in the U.K. Too.
Dr. Eric Chevlen
Dr. Eric Chevlen
Thank
Get help from a real doctor now
Dr. Crystal Twynham
Board Certified, Surgery
30 years in practice
939K people helped
Continue
111,000 doctors available
Read more answers from doctors